


Healthcare News Roundup: Oncology
HSMN NewsFeed - 19 Feb 2014
Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
HSMN NewsFeed - 18 Feb 2014
Rosetta Genomics Appoints Kevin Watson as Director, Reimbursement-Managed Care
Rosetta Genomics Appoints Kevin Watson as Director, Reimbursement-Managed Care
HSMN NewsFeed - 17 Feb 2014
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
HSMN NewsFeed - 12 Feb 2014
Cook Medical Introduces EchoTip(R) ProCore(TM) Endobronchial Ultrasound Needle
Cook Medical Introduces EchoTip(R) ProCore(TM) Endobronchial Ultrasound Needle
HSMN NewsFeed - 10 Feb 2014
Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data
Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data
HSMN NewsFeed - 10 Feb 2014
New Breast Cancer Surgical Guidelines Can Reduce Unnecessary Procedures and Patient Costs
New Breast Cancer Surgical Guidelines Can Reduce Unnecessary Procedures and Patient Costs
HSMN NewsFeed - 31 Jan 2014
ImmunoGen, Inc. Appoints Eric Guempel as Vice President of Product Strategy and Program Management
ImmunoGen, Inc. Appoints Eric Guempel as Vice President of Product Strategy and Program Management
HSMN NewsFeed - 30 Jan 2014
Stem Cell Therapeutics Announces Appointment of Dr. Calvin R. Stiller as Chairman
Stem Cell Therapeutics Announces Appointment of Dr. Calvin R. Stiller as Chairman
HSMN NewsFeed - 29 Jan 2014
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
HSMN NewsFeed - 29 Jan 2014
IsoRay Receives Five Year CE Mark Extension for All Cesium-131 Seed Products
IsoRay Receives Five Year CE Mark Extension for All Cesium-131 Seed Products
HSMN NewsFeed - 29 Jan 2014
Pacific Edge's Cxbladder(TM) Boosting Confidence in Bladder Cancer Detection
Pacific Edge's Cxbladder(TM) Boosting Confidence in Bladder Cancer Detection
HSMN NewsFeed - 29 Jan 2014
Myriad's Prolaris(R) Test Significantly Modifies Treatment Decisions for Patients With Prostate Cancer
Myriad's Prolaris(R) Test Significantly Modifies Treatment Decisions for Patients With Prostate Cancer
HSMN NewsFeed - 16 Jan 2014
CytRx Appoints Shanta Chawla, M.D. as Vice President, Clinical Development
CytRx Appoints Shanta Chawla, M.D. as Vice President, Clinical Development
HSMN NewsFeed - 15 Jan 2014
Varian Medical Systems Receives FDA 510(k) Clearance for its ProBeam(TM) Proton Therapy System
Varian Medical Systems Receives FDA 510(k) Clearance for its ProBeam(TM) Proton Therapy System
HSMN NewsFeed - 13 Jan 2014
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
HSMN NewsFeed - 13 Jan 2014
Agenus Enters into Definitive Agreement to Acquire Privately Held 4-Antibody AG
Agenus Enters into Definitive Agreement to Acquire Privately Held 4-Antibody AG
HSMN NewsFeed - 9 Jan 2014
Sorrento Therapeutics Welcomes William S. Marth as Chairman of the Board of Directors
Sorrento Therapeutics Welcomes William S. Marth as Chairman of the Board of Directors
HSMN NewsFeed - 8 Jan 2014
Sorrento Therapeutics Appoints Amar Singh as Executive Vice President and Chief Business Officer
Sorrento Therapeutics Appoints Amar Singh as Executive Vice President and Chief Business Officer
HSMN NewsFeed - 7 Jan 2014
Cortice Biosciences Announces the Appointment of George Farmer, Ph.D. as Chief Executive Officer
Cortice Biosciences Announces the Appointment of George Farmer, Ph.D. as Chief Executive Officer
HSMN NewsFeed - 6 Jan 2014
PIXUVRI(R) (pixantrone) Receives Positive Final Appraisal Determination from NICE
PIXUVRI(R) (pixantrone) Receives Positive Final Appraisal Determination from NICE
